Site Search

ACS CAN supports legislation that restricts the use of so-called copay accumulator adjustments in health insurance plans.  We advocate for policies that ensure third party prescription drug copay assistance is counted toward patients’ out-of-pocket cost obligations.  Prescription drug affordability safegaurds that patients and their families can care for themselves while reducing the burden of toxic medical debt.   Michigan cancer patients and others rely on prescription drug copay ... two cancer survivors struggles without copay accumulators:  Video of krin_gary_westby_wisconsin   Video of acs_can_barriers_to_care_julie_turner_fc2   Read about the impact of copay accumulators found through our Survivor Views survey: In March & April of 2024, ACS CAN ...

... goal to achieve a 40% reduction in cancer mortality in the United States by 2035. If we are to achieve that goal, we must fight to achieve health equity, the just and fair opportunity for everyone to prevent, find, treat and survive cancer – regardless of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live. Health equity means that everyone has a fair and just opportunity to be as healthy as possible which requires removing obstacles to health such as poverty, discrimination, and their consequences. This event will focus on health equity and its impact on access to care in the cancer space. The panel discussion will include key stakeholders throughout the health community, including leaders in business, ...

WASHINGTON, D.C.—Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ... cancer patients will be relieved to hear their access to innovative new drug therapies will not be in question under this finalized rule. Cancer care often requires specialized treatment targeted at a patient’s specific tumor and these treatments are rarely interchangeable. ... be excluded based on a pre-determined price alone. Concern remains, however, over how this may affect patients starting new therapies. “Cancer care is a race against time. We are glad HHS and Secretary Azar listened to the countless patients who voiced their serious concern over the ...

... is poised to pass a funding bill this week that includes a $2.6 billion increase for medical research at the National Institutes of Health (NIH). The measure, agreed upon by both House and Senate conference committee members, also provides $296 million increase for the National ... and Prevention (CDC), including for skin, prostate and ovarian cancer programs. There is an additional $20 million for the Office on Smoking and Health (OSH).    The bill also includes a measure to raise the federal age of sale for tobacco to 21, extends Medicaid funding for Puerto Rico ... the U.S. territories for two years is critical to helping cancer patients and survivors maintain access to life-saving treatments and follow-up care.    “Similarly, extending funding for federal qualified health centers ensures uninsured and underinsured Americans across the country can ...